Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-066845
Filing Date
2023-06-01
Accepted
2023-06-01 08:00:25
Documents
14
Period of Report
2023-06-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2316204-5_def14a.htm DEF 14A 1101261
2 GRAPHIC lg_promisneuroscienctm-4clr.jpg GRAPHIC 47914
3 GRAPHIC px_ontarioformpg01-4c.jpg GRAPHIC 885789
4 GRAPHIC px_ontarioformpg02-4c.jpg GRAPHIC 748800
5 GRAPHIC px_ontarioformpg03-4c.jpg GRAPHIC 636259
6 GRAPHIC px_ontarioformpg04-4c.jpg GRAPHIC 592584
7 GRAPHIC px_ontarioformpg05-4c.jpg GRAPHIC 1389433
8 GRAPHIC px_ontarioformpg06-4c.jpg GRAPHIC 1955035
9 GRAPHIC px_ontarioformpg07-4c.jpg GRAPHIC 1824367
10 GRAPHIC px_ontarioformpg08-4c.jpg GRAPHIC 1914812
11 GRAPHIC px_ontarioformpg09-4c.jpg GRAPHIC 1386555
12 GRAPHIC px_ontarioformpg10-4c.jpg GRAPHIC 295769
13 GRAPHIC px_promisneuroproxypg01-bw.jpg GRAPHIC 701238
14 GRAPHIC px_promisneuroproxypg02-bw.jpg GRAPHIC 817673
  Complete submission text file 0001104659-23-066845.txt   18211354
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41429 | Film No.: 23983029
SIC: 2834 Pharmaceutical Preparations